Historical salary details - Dr. Emil D. Kakkis, M.D.,PhD, Director, President and Chief Executive Officer, Ultragenyx Pharmaceutical Inc.
Dr. Emil D. Kakkis, M.D.,PhD has been the Director, President and Chief Executive Officer of Ultragenyx Pharmaceutical Inc. since 21 Feb 2010. View his historical salary.
Dr. Emil D. Kakkis, M.D.,Phd
Director, President and Chief Executive Officer
-
Gross Remuneration
-
Current Company
Ultragenyx Pharmaceutical Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Ultragenyx Pharmaceutical Inc. | Director, President and Chief Executive Officer | - | - |
| 2023 | Ultragenyx Pharmaceutical Inc. | Director, President, Chief Executive Officer | 13.1 M | 7.7 % |
| 2022 | Ultragenyx Pharmaceutical Inc. | Director, President, Chief Executive Officer and Principal Financial Officer | 12.1 M | 27.5 % |
| 2021 | Ultragenyx Pharmaceutical Inc. | - | 9.5 M | 85.1 % |
| 2021 | Ultragenyx Pharmaceutical Inc. | President, Chief Executive Officer and Director | 9.5 M | 85.1 % |
| 2020 | Ultragenyx Pharmaceutical Inc. | - | 5.1 M | -21.5 % |
| 2020 | Ultragenyx Pharmaceutical Inc. | - | 5.1 M | -21.5 % |
| 2020 | Ultragenyx Pharmaceutical Inc. | President, Chief Executive Officer and Director | 5.1 M | -21.5 % |
| 2019 | Ultragenyx Pharmaceutical Inc. | President, Chief Executive Officer and Director | 6.6 M | 36.9 % |
| 2019 | Ultragenyx Pharmaceutical Inc. | - | 6.6 M | 36.2 % |
| 2019 | Ultragenyx Pharmaceutical Inc. | - | 6.6 M | 36.2 % |
| 2018 | Ultragenyx Pharmaceutical Inc. | - | 4.8 M | -27.5 % |
| 2018 | Ultragenyx Pharmaceutical Inc. | President, Chief Executive Officer and Director | 4.8 M | -27.5 % |
| 2018 | Ultragenyx Pharmaceutical Inc. | - | 4.8 M | -28.0 % |
| 2017 | Ultragenyx Pharmaceutical Inc. | - | 6.7 M | 51.1 % |
| 2017 | Ultragenyx Pharmaceutical Inc. | President, Chief Executive Officer and Director | 6.7 M | 51.1 % |
| 2017 | Ultragenyx Pharmaceutical Inc. | - | 6.7 M | 51.1 % |
| 2016 | Ultragenyx Pharmaceutical Inc. | - | 4.4 M | -18.1 % |
| 2016 | Ultragenyx Pharmaceutical Inc. | - | 4.4 M | -18.1 % |
| 2016 | Ultragenyx Pharmaceutical Inc. | President, Chief Executive Officer and Director | 4.4 M | -18.1 % |
| 2015 | Ultragenyx Pharmaceutical Inc. | - | 5.4 M | 672.6 % |
| 2015 | Ultragenyx Pharmaceutical Inc. | - | 5.4 M | 672.6 % |
| 2015 | Ultragenyx Pharmaceutical Inc. | President and Chief Executive Officer, Director | 5.4 M | 672.6 % |
| 2014 | Ultragenyx Pharmaceutical Inc. | - | 699.0 K | 2.0 % |
| 2014 | Ultragenyx Pharmaceutical Inc. | - | 699.0 K | 2.0 % |
| 2014 | Ultragenyx Pharmaceutical Inc. | President and Chief Executive Officer, Director | 699.0 K | 2.0 % |
| 2013 | Ultragenyx Pharmaceutical Inc. | - | 685.5 K | 70.8 % |
| 2013 | Ultragenyx Pharmaceutical Inc. | - | 685.5 K | 70.8 % |
| 2013 | Ultragenyx Pharmaceutical Inc. | President and Chief Executive Officer, Director | 685.5 K | 70.8 % |
| 2012 | Ultragenyx Pharmaceutical Inc. | - | 401.4 K | - |
| 2012 | Ultragenyx Pharmaceutical Inc. | - | 401.4 K | - |